Unnamed Mexican manufacturer

Laboratorios Liomont is a leading Mexican pharmaceutical company founded in 1938, specializing in the development, manufacturing, and commercialization of high-quality prescription and over-the-counter medications. The company gained significant international prominence for its strategic partnership with AstraZeneca and the Carlos Slim Foundation to perform the fill-finish manufacturing of the Vaxzevria COVID-19 vaccine for the Latin American region. Liomont operates advanced manufacturing facilities, including a state-of-the-art sterile injectables plant in Ocoyoacac, Mexico, which adheres to international GMP standards. Its extensive product portfolio spans therapeutic areas such as respiratory health, anti-infectives, analgesics, and cardiovascular medicine. As a key player in the Mexican healthcare sector, Liomont continues to expand its capabilities in biotechnology and complex delivery systems.